AXSM - Axsome Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-09    (Delayed quote data   2025-05-09)
Last
 107.76		 Change
 ⇓ -1.10   (-1.01%)		 Volume
  413,065
Open
 108.86		 High
 110.16		 Low
 107.66
8EMA (Daily)
 110.00		 40EMA (Daily)
 110.33		 50EMA (Daily)
 110.51		 STO (Daily)
 51.600		 MACD Hist (Daily)
 0.739
8EMA (Weekly)
 109.291		 40EMA (Weekly)
 101.29		 50EMA (Weekly)
 98.50		 STO (Weekly)
 39.394		 MACD Hist (Weekly)
 -3.501
Company Profile
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com